Previous Article | Next Article 
Journal of Clinical Microbiology, March 1999, p. 758-761, Vol. 37, No. 3
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Spread of Amikacin Resistance in
Acinetobacter baumannii Strains Isolated in Spain Due to an
Epidemic Strain
Jordi
Vila,1,*
Joaquim
Ruiz,1
Margarita
Navia,1
Berta
Becerril,2
Isabel
Garcia,3
Sofia
Perea,4
Inmaculada
Lopez-Hernandez,5
Isabel
Alamo,6
Frederic
Ballester,7
Anna M.
Planes,8
Jesus
Martinez-Beltran,9 and
Teresa Jimenez
De Anta1
Department de Microbiologia, Institut d'
Investigació Biomèdica August Pi i Sunyer, Hospital
Clínic, Facultat de Medicina, Universitat de Barcelona, 08036 Barcelona,1
Servicio de
Microbiología, Hospital Virgen del Rocio, 41013 Seville,2
Servicio de
Microbiología, Hospital de la Princesa, 28006 Madrid,3
Servicio de Microbiologia,
Hospital 12 de Octubre, 28041 Madrid,4
Departamento de Microbiología y Epidemiología
Infecciosa, Hospital Virgen Macarena, 41008 Seville,5
Servicio de
Microbiología, Hospital Nuestra Señora del Pino, 35005 Las Palmas, Grand Canary Islands,6
Servicio de Microbiología, Hospital de Sant Joan de
Reus, 43201 Reus, Tarragona,7
Servicio
de Microbiología, Hospital del Valle Hebrón, 08035 Barcelona,8 and
Servicio de
Microbiología, Hospital Ramón y Cajal, 28034 Madrid,9 Spain
Received 29 April 1998/Returned for modification 2 July
1998/Accepted 8 December 1998
Sixteen amikacin-resistant clinical Acinetobacter
baumannii isolates from nine different hospitals in Spain were
investigated to determine whether the high incidence of
amikacin-resistant A. baumannii was due to the
dissemination of an amikacin-resistant strain or to the spread of an
amikacin resistance gene. The epidemiological relationship studied by
repetitive extragenic palindromic PCR and low-frequency restriction
analysis of chromosomal DNA showed that the same clone was isolated in
eight of nine hospitals, although other clones were also found. The
strains were studied for the presence of the aph(3')-VIa
and aac(6')-I genes, which encode enzymes which inactivate
amikacin, by PCR. All 16 clinical isolates had positive PCRs with
primers specific for the amplification of the aph(3')-VIa
gene, whereas none had a positive reaction for the amplification of the
aac(6')-I gene. Therefore, the high incidence of amikacin
resistance among clinical A. baumannii isolates in Spain
was mainly due to an epidemic strain, although the spread of the
aph(3')-VI gene cannot be ruled out.
*
Corresponding author. Mailing address: Laboratori de
Microbiologia, Hospital Clinic, Facultat de Medicina, Universitat de Barcelona, Villarroel, 170, 08036 Barcelona, Spain. Phone:
34-3-2275522. Fax: 34-3-2275454. E-mail:
vila{at}medicina.ub.es.
Journal of Clinical Microbiology, March 1999, p. 758-761, Vol. 37, No. 3
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Boo, T. W., Walsh, F., Crowley, B.
(2009). Molecular characterization of carbapenem-resistant Acinetobacter species in an Irish university hospital: predominance of Acinetobacter genomic species 3. J Med Microbiol
58: 209-216
[Abstract]
[Full Text]
-
Adams-Haduch, J. M., Paterson, D. L., Sidjabat, H. E., Pasculle, A. W., Potoski, B. A., Muto, C. A., Harrison, L. H., Doi, Y.
(2008). Genetic Basis of Multidrug Resistance in Acinetobacter baumannii Clinical Isolates at a Tertiary Medical Center in Pennsylvania. Antimicrob. Agents Chemother.
52: 3837-3843
[Abstract]
[Full Text]
-
Peleg, A. Y., Seifert, H., Paterson, D. L.
(2008). Acinetobacter baumannii: Emergence of a Successful Pathogen. Clin. Microbiol. Rev.
21: 538-582
[Abstract]
[Full Text]
-
Scheetz, M. H., Qi, C., Warren, J. R., Postelnick, M. J., Zembower, T., Obias, A., Noskin, G. A.
(2007). In Vitro Activities of Various Antimicrobials Alone and in Combination with Tigecycline against Carbapenem-Intermediate or -Resistant Acinetobacter baumannii. Antimicrob. Agents Chemother.
51: 1621-1626
[Abstract]
[Full Text]
-
Nemec, A., Dolzani, L., Brisse, S., van den Broek, P., Dijkshoorn, L.
(2004). Diversity of aminoglycoside-resistance genes and their association with class 1 integrons among strains of pan-European Acinetobacter baumannii clones. J Med Microbiol
53: 1233-1240
[Abstract]
[Full Text]
-
Swenson, J. M., Killgore, G. E., Tenover, F. C.
(2004). Antimicrobial Susceptibility Testing of Acinetobacter spp. by NCCLS Broth Microdilution and Disk Diffusion Methods. J. Clin. Microbiol.
42: 5102-5108
[Abstract]
[Full Text]
-
Zarrilli, R., Crispino, M., Bagattini, M., Barretta, E., Di Popolo, A., Triassi, M., Villari, P.
(2004). Molecular Epidemiology of Sequential Outbreaks of Acinetobacter baumannii in an Intensive Care Unit Shows the Emergence of Carbapenem Resistance. J. Clin. Microbiol.
42: 946-953
[Abstract]
[Full Text]
-
Houang, E. T. S., Chu, Y.-W., Lo, W.-S., Chu, K.-Y., Cheng, A. F. B.
(2003). Epidemiology of Rifampin ADP-Ribosyltransferase (arr-2) and Metallo-{beta}-Lactamase (blaIMP-4) Gene Cassettes in Class 1 Integrons in Acinetobacter Strains Isolated from Blood Cultures in 1997 to 2000. Antimicrob. Agents Chemother.
47: 1382-1390
[Abstract]
[Full Text]
-
Lopez-Otsoa, F., Gallego, L., Towner, K. J., Tysall, L., Woodford, N., Livermore, D. M.
(2002). Endemic Carbapenem Resistance Associated with OXA-40 Carbapenemase among Acinetobacter baumannii Isolates from a Hospital in Northern Spain. J. Clin. Microbiol.
40: 4741-4743
[Abstract]
[Full Text]
-
Danes, C., Navia, M. M., Ruiz, J., Marco, F., Jurado, A., Jimenez de Anta, M. T., Vila, J.
(2002). Distribution of {beta}-lactamases in Acinetobacter baumannii clinical isolates and the effect of Syn 2190 (AmpC inhibitor) on the MICs of different {beta}-lactam antibiotics. J Antimicrob Chemother
50: 261-264
[Abstract]
[Full Text]
-
Pantophlet, R., Severin, J. A., Nemec, A., Brade, L., Dijkshoorn, L., Brade, H.
(2002). Identification of Acinetobacter Isolates from Species Belonging to the Acinetobacter calcoaceticus-Acinetobacter baumannii Complex with Monoclonal Antibodies Specific for O Antigens of Their Lipopolysaccharides. CVI
9: 60-65
[Abstract]
[Full Text]
-
GALLEGO, L., TOWNER, K. J.
(2001). Carriage of class 1 integrons and antibiotic resistance in clinical isolates of Acinetobacter baumannii from Northern Spain. J Med Microbiol
50: 71-77
[Abstract]
[Full Text]
-
Corbella, X., Montero, A., Pujol, M., Domínguez, M. A., Ayats, J., Argerich, M. J., Garrigosa, F., Ariza, J., Gudiol, F.
(2000). Emergence and Rapid Spread of Carbapenem Resistance during a Large and Sustained Hospital Outbreak of Multiresistant Acinetobacter baumannii. J. Clin. Microbiol.
38: 4086-4095
[Abstract]
[Full Text]
-
Brisse, S., Milatovic, D., Fluit, A. C., Kusters, K., Toelstra, A., Verhoef, J., Schmitz, F.-J.
(2000). Molecular Surveillance of European Quinolone-Resistant Clinical Isolates of Pseudomonas aeruginosa and Acinetobacter spp. Using Automated Ribotyping. J. Clin. Microbiol.
38: 3636-3645
[Abstract]
[Full Text]
-
Heinemann, B., Wisplinghoff, H., Edmond, M., Seifert, H.
(2000). Comparative Activities of Ciprofloxacin, Clinafloxacin, Gatifloxacin, Gemifloxacin, Levofloxacin, Moxifloxacin, and Trovafloxacin against Epidemiologically Defined Acinetobacter baumannii Strains. Antimicrob. Agents Chemother.
44: 2211-2213
[Abstract]
[Full Text]
-
Takahashi, A., Yomoda, S., Kobayashi, I., Okubo, T., Tsunoda, M., Iyobe, S.
(2000). Detection of Carbapenemase-Producing Acinetobacter baumannii in a Hospital. J. Clin. Microbiol.
38: 526-529
[Abstract]
[Full Text]